Applying health economics for policy decision making: do devices differ from drugs?

TY - JOUR

T1 - Applying health economics for policy decision making

T2 - do devices differ from drugs?

AU - Sorenson, C.

AU - Tarricone, R.

AU - Siebert, M.

AU - Drummond, M.F.

PY - 2011/5

Y1 - 2011/5

N2 - Medical devices pose unique challenges for economic evaluation and associated decision-making processes that differ from pharmaceuticals. We highlight and discuss these challenges in the context of cardiac device therapy, based on a systematic review of relevant economic evaluations. Key challenges include practical difficulties in conducting randomized clinical trials, allowing for a ‘learning curve’ and user characteristics, accounting for the wider organizational impacts of introducing new devices and allowing for variations in product characteristics and prices over time.

AB - Medical devices pose unique challenges for economic evaluation and associated decision-making processes that differ from pharmaceuticals. We highlight and discuss these challenges in the context of cardiac device therapy, based on a systematic review of relevant economic evaluations. Key challenges include practical difficulties in conducting randomized clinical trials, allowing for a ‘learning curve’ and user characteristics, accounting for the wider organizational impacts of introducing new devices and allowing for variations in product characteristics and prices over time.

KW - Medical devices

KW - Cardiology

KW - Economic evaluation

KW - Health technology assessment

UR - http://www.scopus.com/inward/record.url?scp=79955637666&partnerID=8YFLogxK

U2 - doi:10.1093/europace/eur089

DO - doi:10.1093/europace/eur089

M3 - Article

VL - 13

SP - ii54-ii58

JO - Europace Spotlight Supplement

JF - Europace Spotlight Supplement

IS - SUPPL. 2

ER -